Robert Kline — President, Chief Executive Officer
Robert is a serial entrepreneur and executive with over 25 years of experience in the healthcare and life science industries. Most recently he was President and CEO of ViroCyt, Inc. ViroCyt was founded to develop and commercialize rapid virus quantification methods which can be used to accelerate development of new vaccines and gene therapy applications. The company’s products were quickly adopted by leading pharmaceutical and biotech companies and ViroCyt was acquired by Sartorius AG in July 2016. Previously Robert was the Founder, President and CEO of Medivance, Inc., which he built into the worldwide leader in therapeutic hypothermia treatment for critically ill patients. Medivance was acquired by CR Bard in 2011 for $260M and Robert was named Entrepreneur of the Year for the Mountain/Desert Region by Ernst and Young. Prior to Medivance, Robert held senior management positions at Pfizer and Covidien. Robert earned a MBA from the University of Colorado, a MS in Microbiology from the University of Illinois and a BA in chemistry from Colorado College.
Zach Stassen — Chief Financial Officer, Chief Operating Officer
Zach has over 19 years of experience in the medical device and healthcare industry. Most recently, Zach served as Vice President of Finance at Spectranetics until it was acquired by Philips in 2017 for $2.2B. Prior to Spectranetics, Zach was Co-founder and CFO at Emerge Medical, a company focused on generic orthopedic trauma products. Emerge was acquired by Cardinal Health in 2014. Earlier in his career, Zach served as a member of Piper Jaffray’s medical technology team, completing numerous public and private financing transactions as well as several M&A assignments. Zach holds an MBA from the Kellogg School of Management at Northwestern University and a BS from Drake University.
Dale Schmaltz — Chief Technical Officer
Donna Ford-Serbu — Vice President of Sales and Marketing
Donna has over 22 years of experience in the medical devices. She most recently served as SVP, Lead Management with commercial and R&D responsibilities at Spectranetics until the company was sold to Philips for $2.2B in summer 2017.
Prior to Spectranetics, Donna spent 13 years at Covidien, the last 3 years with Respiratory and Monitoring Solutions where she drove efforts to transform Patient Monitoring resulting in 32% growth through organic programs and acquisition of two companies, Aspect Medical and Somanetics. She spent 10 years with the Energy-based Devices division, holding positions of increasing responsibility in the areas of sales and marketing management, business development, and strategy and portfolio.
Donna is a co-founder and serves on the board of Eximis Surgical. She holds an MBA from the University of Rochester, and a BS from the University of Colorado.
Robert Luzzi — Vice President of Product Development
Bob has over 25 years in the medical device industry, most recently serving as VP of R&D for Woven Orthopedic Technologies, an early stage orthopedic/spine biotextile implant company. Bob is an expert in leading technically-diverse product development programs as well as designing and implementing regulatory, quality systems, and clinical research programs for emerging technology companies. Bob has led product development initiatives for both multi-national and start-up medical device companies and has helped shepherd 38 product lines and over 110 products from concept to commercialization. Bob is also an inventor on 45 pending patents and is a Certified Patent Agent. Previously Bob held senior management positions at Sky Medical Development, DFine Inc., Johnson & Johnson, and Medtronic. He holds a MS degree in Mechanical Engineering from Clarkson University, a MS in Bioengineering and BS in Bioengineering from University of Illinois at Urbana-Champaign.